How to choose an online GLP-1 provider
Direct answer
What you need to know
Evidence strength: ModerateOnline GLP-1 providers are narrowed by four facts about you, not by which service is best — your state, your insurance, the product you need, and what you will pay once introductory pricing ends. The first of those eliminates more providers than the other three combined, and it is the one the field publishes worst: 9 of the 15 services we list publish no state-coverage list at all. Choosing well is mostly a matter of knowing which questions the published record can answer, and which you have to ask before you hand over a card.
Key takeaways
- Eliminate before you compare. Four filters usually reduce 15 services to two or three real options.
- Only two providers name the specific states they cannot serve. Most of the rest assert nationwide availability without a list.
- A compounded product is not an FDA-approved medicine, whatever molecule it contains. All 15 records disclose where compounding is involved.
- The quoted price is usually not the recurring one: membership and medication are charged separately, and introductory rates end.
Important limitation: We report what providers publish about themselves, counted at the date on this page. We have not inspected a pharmacy, verified a licence, or tested whether a service will accept you — and 6 of our 15 records carry a re-check we could not complete, which is recorded on the record rather than smoothed over.
Next action: Once you know your filters, the fifteen provider records set out what each service states about itself, unranked. If cost is the binding constraint, every route priced side by side is the better starting point.
Primary sources: U.S. Food & Drug Administration, DailyMed, U.S. National Library of Medicine
General education, not medical advice. A listing is not a recommendation, and nothing here is a recommendation to start any medication.
The four questions that actually eliminate providers
Almost every page answering this question ranks services. Ranking assumes the reader is interchangeable, and in this category they are not: the same provider is the obvious choice for one person and unavailable to the next. So the useful question is not which service is best but which ones are still standing after your own constraints are applied — and whether the published record can tell you.
| What you need to know | Why it decides the outcome | Answerable from published information? | What we hold |
|---|---|---|---|
| Does it operate in my state? | The only criterion that can disqualify a provider outright, whatever else it offers. | Rarely | 9 of 15 publish no state list at all |
| Will it work with my insurance? | Decides whether you are paying a copay or the full cash price, which are different orders of magnitude. | Sometimes | 6 of 15 describe billing or working with insurance |
| Brand-name or compounded? | A compounded product is not an FDA-approved medicine, and the distinction is not always made prominent at signup. | Yes | all 15 carry a compounding disclosure in their record |
| What will I pay in month four? | Introductory pricing and membership fees are quoted separately from medication, so the first invoice is rarely the recurring one. | Partly | membership fee and medication cost are held as separate fields |
| Is what I am reading still true? | Prices and terms in this category move faster than any page describing them. | Marked | 6 of 15 records carry a re-check we could not complete |
The filter that decides most, published least
A telehealth service can only prescribe where its clinicians are licensed. That makes state coverage the one criterion capable of ruling a provider out no matter how good it is — and it is the criterion the category publishes worst. Of the 15 services we list, 9 publish no state list anywhere a reader could check before signing up. Their records carry the same phrase, because it is the honest description of what is available: not published in a single state-coverage list, confirm at signup.
The 6 that do publish something mostly assert nationwide coverage rather than naming states, which is a claim rather than a list. Only 2 put a checkable answer in writing, and both do it as an exclusion — the states where they cannot serve you:
- Alloy — Compounded semaglutide not available in AL, AR, CA, DC, LA, MS, and NV.
- Delilah — Available in every state except Mississippi.
Those are the only records on which you can settle the question before you sign up. For everyone else it is a question to ask, and the cheapest one to ask first.
A ranked list cannot tell you the one thing most likely to disqualify a provider, because the answer is different for every reader and most of the field does not publish it.
Why the first price is rarely the recurring one
Two charges make up what you pay, and they are quoted separately: a membership or consultation fee for the service, and the cost of the medication itself. A headline figure may be either one, and introductory pricing frequently covers only the first month or two. Our records hold those as separate fields for exactly that reason — a single blended number would look more useful and mean less.
The practical move is to work out the month-four cost before you sign up rather than the month-one cost, and to check whether the tier you are quoted is a compounded product or a brand-name one, because that is usually where the difference sits.
Compounded and brand-name are not the same purchase
A compounded preparation is made by a pharmacy to order rather than manufactured and approved as a finished product. It has not been through FDA review for safety, effectiveness or manufacturing quality, even when the active molecule is the same as an approved drug’s. What compounding actually involves is worth reading before choosing on price alone, because the lower-cost tier at most services is the compounded one.
This is not an argument that compounded products are unsafe. It is a statement about what has been verified and what has not, and it is information you are entitled to have before you choose, which is why every record in the directory carries a compounding disclosure whether or not the provider leads with it.
What to ask before you pay
Are you licensed to prescribe in my state?
Ask first, because a no ends the conversation and costs you nothing. For 9 of the 15 services we list, this is the only way to find out.
Is the product you would prescribe FDA-approved or compounded?
A service can legitimately offer both. What matters is that you know which one you are being sold, and at which price tier — the answer should be specific rather than a reassurance about quality.
What is the total monthly cost after the introductory period?
Ask for the membership fee and the medication cost separately, and ask when the introductory rate ends. A service that cannot answer this cleanly is quoting you a marketing figure.
Will a clinician review my history before anything is dispensed?
Both live and asynchronous review are genuine and legal. What the assessment actually involves sets out the five stages, including the one most guides leave out: what happens when the answer is no.
What happens if I need to stop, or it does not work?
Ask how cancellation works, whether the membership is billed monthly or quarterly, and whether anything you have paid for is refundable. Billing period is one of the details most often discovered after the fact.
What this page cannot tell you
It cannot tell you which provider is best, because that depends on your state, your insurance, your history and the product you need — and it cannot tell you whether a service will accept you, because that is a clinical decision made after an assessment. It also cannot tell you that a figure quoted here is still current: this category changes its pricing faster than any page describing it, which is why the dated log of what has changed exists and why 6 of our records openly carry a re-check that failed. The standard a provider has to meet to appear at all sets out which of these facts we verify and which we publish as stated.
Common questions
How do you choose an online GLP-1 provider?
Start by eliminating rather than ranking. Four things disqualify a provider before quality is even in question: whether it operates in your state, whether it works with your insurance, whether it prescribes the product you need, and what the recurring price is once introductory pricing ends. Most people find that two or three services survive those filters, at which point the choice is between a small number of real options rather than a field of fifteen.
Is it safe to get a GLP-1 prescription online?
Telehealth prescribing of GLP-1 medications is legal and routine in the United States, and every provider in our directory requires a medical evaluation before prescribing. The thing worth checking is not whether a service is online but whether its intake actually screens you — a form that asks for your goal weight and your card details but never asks about thyroid cancer, pancreatitis or pregnancy is not performing an assessment.
Why will nobody tell me which provider is best?
Because the answer depends on facts about you that no page holds — your state, your insurance, your medical history, and which product you have been prescribed. Sites that publish a ranked top ten are ranking against a reader who does not exist, and most of them take a referral fee from services in the list. We publish what each provider states about itself, unranked, and let the filters do the work.
How can I tell if a provider operates in my state?
Usually by asking, which is the finding on this page. 9 of the 15 services we list publish no state-coverage list anywhere a reader could check before signing up. Of the 6 that publish something, most assert nationwide availability without naming states. Only two name specific states, and both do it as an exclusion — the states where they cannot serve you.
Is a compounded GLP-1 the same medicine as the brand-name one?
No. A compounded preparation is made by a pharmacy rather than manufactured and approved as a finished product, so it has not been through FDA review for safety, effectiveness or manufacturing quality — even when it contains the same active molecule. That is not a claim that compounded products are unsafe; it is a statement about what has and has not been verified, and it is the single thing most worth understanding before choosing a lower-priced tier.
Sources
Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.
- Drug approvals, labeling and safety communicationsU.S. Food & Drug AdministrationSupports: That GLP-1 receptor agonists are prescription-only medicines in the United States, and that compounded versions are not FDA-approved products.
- FDA-approved prescribing information (drug labels)DailyMed, U.S. National Library of MedicineSupports: The approved indications and labelled contraindications a legitimate intake is screening against.
- Patient drug and condition informationMedlinePlus, U.S. National Library of MedicineSupports: Plain-language background on what a prescriber needs from a patient history before prescribing.
This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.